CLOVES syndrome: Treatment with oral Rapamycin. Report of two cases.

Introduction: CLOVES syndrome is characterized by lipomatous overgrowth associated with vascular malforma tions, representing a diagnostic and a therapeutic challenge. Rapamycin, an mTOR inhibitor, has proved to be a good therapeutic option in some vascular anomalies. In this article, we report two ca ses of CLOVES syndrome with good response to oral rapamycin treatment.

[Erythema nodosum: Analysis of 91 hospitalized patients].

Background: Erythema Nodosum (EN) is an acute nodular erythematous cutaneous eruption. It is presumed to be a hypersensitivity reaction and it may be idiopathic, or occur in association with diverse diseases and medications.

Aim: To identify the main etiologies of EN among patients admitted to a medicine service of a clinical hospital.